+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Combination of 5-fluorouracil and irinotecan on modulation of thymidylate synthase and topoisomerase I expression and cell cycle regulation in human colon cancer LoVo cells: clinical relevance



Combination of 5-fluorouracil and irinotecan on modulation of thymidylate synthase and topoisomerase I expression and cell cycle regulation in human colon cancer LoVo cells: clinical relevance



Clinical Colorectal Cancer 2(3): 182-188



This study was designed to explore the possible interaction of 5-fluorouracil (5-FU) and 7-ethyl-10-hydroxycamptothecin (SN-38) in vitro. Human colon cancer LoVo cells were treated in both a dose- and time-dependent manner using clinically relevant concentrations of and exposure to 5-FU and/or SN-38. The expression of thymidylate synthase (TS), topoisomerase I, and cell cycle kinetics were evaluated by Western blot analysis and flow cytometry, respectively. Cytotoxicity was evaluated by MTT (3-[4,5-dimethylthiazol-2yl]-2,5-diphenyl tetrazolium bromide) assay. The cytotoxic effects of combination treatment were determined by median effect analysis. Topoisomerase I expression was downregulated following 12 hours of exposure to treatment, and topoisomerase I expression recovered 8 hours after SN-38 was removed. The TS expression was decreased following 24 hours of 5-FU and it remained at reduced levels for > 24 hours after removal of 5-FU. SN-38 induced an arrest at S/G2/M phase, reaching its maximum effect at 12 hours. This cell cycle arrest was reversed 24 hours after SN-38 was removed. 5-FU induced an arrest at the S phase, and maximum arrest occurred at 12 hours and lasted for > 48 hours. After 12 hours of sequential SN-38, LoVo cells were arrested in S phase, thereby potentiating the effect of 5-FU. Cytotoxicity studies confirmed the synergistic interaction between 5-FU and irinotecan. These findings suggest that the proper sequencing of 5-FU/irinotecan depends on regulation of topoisomerase I, and cell cycle kinetics

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 045566811

Download citation: RISBibTeXText

PMID: 12482336

DOI: 10.3816/ccc.2002.n.023


Related references

Thymidylate synthase gene expression and cell cycle phase distribution after irinotecan administration Implications for the synergistic effect of sequential irinotecan/5-fluorouracil in the HT-29 human colon carcinoma cell line. Proceedings of the American Association for Cancer Research Annual Meeting 43: 258, 2002

Irinotecan overcomes the resistance to 5-fluorouracil in human colon cancer xenografts by down-regulation of intratumoral thymidylate synthase. Oncology Reports 24(4): 835-842, 2011

Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma. Advances in Experimental Medicine and Biology 339: 143-51; Discussion 165-7, 1993

Comparative analysis of thymidylate synthase expression and cell cycle profile after topotecan or irinotecan +- 5-fluorouracil exposure. Proceedings of the American Association for Cancer Research Annual Meeting 40: 400, 1999

Prognostic value of thymidylate synthase, topoisomerase-1 and Ki-67 in advanced colorectal cancer patients on irinotecan and fluorouracil treatment. Zhonghua Zhong Liu Za Zhi 27(5): 312-315, 2005

Transcriptional activation and cell cycle block are the keys for 5-fluorouracil induced up-regulation of human thymidylate synthase expression. Plos One 7(10): E47318, 2013

Translational regulation of thymidylate synthase in response to 5 fluorouracil and gamma interferon in a human colon cancer cell line h630. Proceedings of the American Association for Cancer Research Annual Meeting 32: 416, 1991

Dynamic modulation of thymidylate synthase gene expression and fluorouracil sensitivity in human colorectal cancer cells. Plos One 10(4): E0123076, 2016

The correlation between thymidylate synthase expression and cytotoxicity of 5-fluorouracil in human cancer cell lines: study using polyclonal antibody against recombinant human thymidylate synthase. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(6): 705-712, 1997

Interference with thymidylate synthase activity and DNA integrity in the HT-29 human colon carcinoma cell line not by 5-fluorouracil before irinotecan but by the reversed sequence and simultaneous drug treatment. Proceedings of the American Association for Cancer Research Annual Meeting 42: 509, 2001

Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. Clinical Cancer Research 5(3): 643-654, 1999

The effects of combination of fluorouracil with p14ARF gene transfection on human colon cancer cell line LOVO. Fudan Xuebao 33(1): 63-67,73, 2006

Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed. European Journal of Cancer 36(7): 916-924, 2000

Effects of RNA interference and nolatrexed on thymidylate synthase expression and cell proliferation of human colorectal carcinoma LOVO cells. Zhonghua Wei Chang Wai Ke Za Zhi 15(11): 1187-1191, 2014

Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil. Biochemical Pharmacology 49(10): 1419-1426, 1995